Five initial public offerings collectively raised $1.3 billion during the past week, bringing the year's total to 228 IPOs and $73.5 billion raised, a 35% increase over this time last year by deal count and an 84% increase by proceeds. The S&P 500 had the...read more
One step Forward, two steps back Forward Pharma (FWP), which is developing an alternative to and challenging the IP of Biogen Idec's multi-billion dollar Tecfidera treatment for MS, raised $221 and finished its first day down 17%. It was the year's...read more
Forward Pharma, which is developing an alternative to and challenging IP of Biogen Idec's Tecfidera for MS, raised $221 million by offering 10.5 million shares at $21, the midpoint of the range of $20-$22. Forward Pharma plans to list on the NASDAQ under the...read more
Seven initial public offerings are expected to raise $1.7 billion in the upcoming week. Four IPOs are biotechs, including Forward Pharma, which could be the year's largest (and 60th), and three others in early stages of development. Consolidated fiber optic...read more
US IPO Weekly Recap: 5 IPOs achieve moderate gains during the market slide and a biotech rejection
Five initial public offerings collectively raised $1.3 billion during the past week, bringing the year's total to 228 IPOs and $73.5 billion raised, a 35% increase over this time last year by deal count and an 84% increase by proceeds. The S&P 500 had the...read more
Forward Pharma goes backward: year's largest biotech drops 17% on IPO
One step Forward, two steps back Forward Pharma (FWP), which is developing an alternative to and challenging the IP of Biogen Idec's multi-billion dollar Tecfidera treatment for MS, raised $221 and finished its first day down 17%. It was the year's...read more
Forward Pharma prices IPO at the $21 midpoint
Forward Pharma, which is developing an alternative to and challenging IP of Biogen Idec's Tecfidera for MS, raised $221 million by offering 10.5 million shares at $21, the midpoint of the range of $20-$22. Forward Pharma plans to list on the NASDAQ under the...read more
7 US IPOs planned for the week of October 13, including the IPO market's biotech test
Seven initial public offerings are expected to raise $1.7 billion in the upcoming week. Four IPOs are biotechs, including Forward Pharma, which could be the year's largest (and 60th), and three others in early stages of development. Consolidated fiber optic...read more